306 related articles for article (PubMed ID: 31205194)
1. Characteristics of Patients Experiencing Extrapyramidal Symptoms or Other Movement Disorders Related to Dopamine Receptor Blocking Agent Therapy.
Musco S; Ruekert L; Myers J; Anderson D; Welling M; Cunningham EA
J Clin Psychopharmacol; 2019; 39(4):336-343. PubMed ID: 31205194
[TBL] [Abstract][Full Text] [Related]
2. Clinical Spectrum of Drug-Induced Movement Disorders: A Study of 97 Patients.
Chouksey A; Pandey S
Tremor Other Hyperkinet Mov (N Y); 2020 Oct; 10():48. PubMed ID: 33178486
[TBL] [Abstract][Full Text] [Related]
3. Setting the record straight: The nosology of tardive syndromes.
Truong DD; Frei K
Parkinsonism Relat Disord; 2019 Feb; 59():146-150. PubMed ID: 30528171
[TBL] [Abstract][Full Text] [Related]
4. An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders.
Vanegas-Arroyave N; Caroff SN; Citrome L; Crasta J; McIntyre RS; Meyer JM; Patel A; Smith JM; Farahmand K; Manahan R; Lundt L; Cicero SA
CNS Drugs; 2024 Apr; 38(4):239-254. PubMed ID: 38502289
[TBL] [Abstract][Full Text] [Related]
5. The nosology of tardive syndromes.
Frei K; Truong DD; Fahn S; Jankovic J; Hauser RA
J Neurol Sci; 2018 Jun; 389():10-16. PubMed ID: 29433810
[TBL] [Abstract][Full Text] [Related]
6. Adverse effects of antipsychotic drugs.
Malhotra AK; Litman RE; Pickar D
Drug Saf; 1993 Dec; 9(6):429-36. PubMed ID: 7907481
[TBL] [Abstract][Full Text] [Related]
7. Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice.
Hauser RA; Meyer JM; Factor SA; Comella CL; Tanner CM; Xavier RM; Caroff SN; Lundt L
CNS Spectr; 2022 Apr; 27(2):208-217. PubMed ID: 33213556
[TBL] [Abstract][Full Text] [Related]
8. The Relationship Between Early Haloperidol Response and Associated Extrapyramidal Side Effects.
Rasmussen SA; Rosebush PI; Mazurek MF
J Clin Psychopharmacol; 2017 Feb; 37(1):8-12. PubMed ID: 28027109
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of Inpatients Prescribed Dopamine Receptor Blocking Agents.
Schwartz S; Dinkla L; Pullen J; Bernard R; Kumar A
Psychopharmacol Bull; 2021 Nov; 51(4):51-64. PubMed ID: 34887599
[TBL] [Abstract][Full Text] [Related]
10. Movement side effects of antipsychotic drugs in adults with and without intellectual disability: UK population-based cohort study.
Sheehan R; Horsfall L; Strydom A; Osborn D; Walters K; Hassiotis A
BMJ Open; 2017 Aug; 7(8):e017406. PubMed ID: 28775195
[TBL] [Abstract][Full Text] [Related]
11. The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curaçao Extrapyramidal Syndromes Study II.
van Harten PN; Hoek HW; Matroos GE; Koeter M; Kahn RS
Schizophr Res; 1997 Aug; 26(2-3):235-42. PubMed ID: 9323356
[TBL] [Abstract][Full Text] [Related]
12. Movement disorders associated with neuroleptic treatment.
Wirshing WC
J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic-induced movement disorders: an overview.
Sachdev PS
Psychiatr Clin North Am; 2005 Mar; 28(1):255-74, x. PubMed ID: 15733622
[No Abstract] [Full Text] [Related]
14. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
Ganzini L; Casey DE; Hoffman WF; McCall AL
Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
[TBL] [Abstract][Full Text] [Related]
15. Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.
Barnes TR; McPhillips MA
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S49-57. PubMed ID: 9690971
[TBL] [Abstract][Full Text] [Related]
16. Movement disorders with neuroleptic drug treatment.
Tarsy D
Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acute neuroleptic-induced movement disorders.
Tonda ME; Guthrie SK
Pharmacotherapy; 1994; 14(5):543-60. PubMed ID: 7997388
[TBL] [Abstract][Full Text] [Related]
18. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
[TBL] [Abstract][Full Text] [Related]
19. Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations.
J Clin Psychiatry; 1998; 59 Suppl 12():23-7. PubMed ID: 9766616
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao Extrapyramidal Syndromes Study: I.
van Harten PN; Matroos GE; Hoek HW; Kahn RS
Schizophr Res; 1996 May; 19(2-3):195-203. PubMed ID: 8789918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
